EUVIMEDEUVIMED entdecken
Systematische ÜbersichtÜbersichtsarbeitUmbrella Review

Predictive neuroimaging biomarkers of major depressive disorder treatment response: An umbrella review

Yasmin Esmaeilian, Ahmadreza Samimi, Sajjad Mousavi, Iman Kiani iD, Giulia Cattarinussi, Hossein Sanjari Moghaddam

Psychiatry and Clinical Neurosciences · 2026-06 · 80 (6) · 459-468

DOI: 10.1111/pcn.70053 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Psychiatry and Clinical Neurosciences, online erschienen am 05.04.2026. Verfasst von Yasmin Esmaeilian und 5 weiteren Autor:innen. Beteiligte Einrichtung: Students' Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Major Depressive Disorder, Neuroimaging, Outcome Assessment, Health Care. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 56 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Major depressive disorder (MDD) is a heterogeneous condition with varied responses to pharmacological, psychotherapeutic, and neuromodulation interventions. Identifying neuroimaging biomarkers predictive of treatment response could facilitate personalized treatment selection. This umbrella review synthesized findings from systematic reviews and meta‐analyses evaluating neuroimaging biomarkers predictive of treatment response in MDD. A comprehensive search was conducted across PubMed, Scopus, Web of Science, and Embase. Fourteen systematic reviews and meta‐analyses, encompassing 17,855 individuals with MDD, were included. Imaging modalities assessed included structural MRI, functional MRI (resting‐state and task‐based), diffusion tensor imaging, PET, MEG, and fNIRS. Methodological quality was evaluated using the Measurement Tool to Assess Systematic Reviews (AMSTAR 2 tool). The most consistently predictive biomarkers were increased volume and activity in the anterior cingulate cortex (ACC) and hippocampus and altered functional connectivity in the default mode network (DMN) and fronto‐limbic circuits. Predictive patterns varied by treatment modality: for example, larger hippocampal volume predicted pharmacotherapy response, while smaller hippocampal volume was associated with better outcomes in ECT. Machine learning models integrating multimodal data achieved high predictive accuracy (AUC >0.85), though most lacked external validation. Evidence quality was low to very low among the included studies due to methodological heterogeneity. Neuroimaging biomarkers, particularly involving ACC, hippocampus, and large‐scale functional networks, hold promise for guiding treatment selection in MDD. Integration of multimodal imaging and computational approaches may enhance predictive accuracy. However, standardization and prospective validation in clinical settings are needed for translation into practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Major Depressive DisorderNeuroimagingOutcome Assessment, Health CareHumansBiomarkers

Stichwörter der Autor:innen

major depressive disorderneuroimagingumbrella review

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Students' Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Department of Neuroscience (DNS), Padua Neuroscience Center, University of Padova, Padua, Italy.
  • Padua Neuroscience Center, University of Padova, Padua, Italy.
  • Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
  • Medical School, Tehran University of Medical Sciences, Tehran, Iran.

ORCID-Profile: Iman Kiani

Zitieren

APA

Esmaeilian, Y., Samimi, A., Mousavi, S., Kiani, I., Cattarinussi, G., & Sanjari Moghaddam, H. (2026). Predictive neuroimaging biomarkers of major depressive disorder treatment response: An umbrella review. Psychiatry and Clinical Neurosciences, 80(6), 459-468. https://doi.org/10.1111/pcn.70053

Vancouver

Esmaeilian Y, Samimi A, Mousavi S, Kiani I, Cattarinussi G, Sanjari Moghaddam H. Predictive neuroimaging biomarkers of major depressive disorder treatment response: An umbrella review. Psychiatry and Clinical Neurosciences. 2026;80(6):459-468. doi:10.1111/pcn.70053

BibTeX
@article{Esmaeilian2026,
  author = {Esmaeilian, Yasmin and Samimi, Ahmadreza and Mousavi, Sajjad and Kiani, Iman and Cattarinussi, Giulia and Sanjari Moghaddam, Hossein},
  title = {Predictive neuroimaging biomarkers of major depressive disorder treatment response: An umbrella review},
  journal = {Psychiatry and Clinical Neurosciences},
  year = {2026},
  volume = {80},
  number = {6},
  pages = {459--468},
  doi = {10.1111/pcn.70053}
}
Kostenlos starten →